Xuebing Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xuebing Wang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Claire Yik-Lok Chung
Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
4 shared publications - Hideki Tanizawa
Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
4 shared publications - Ken-Ichi Noma
Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
4 shared publications - Shinya Ohta
Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
4 shared publications - Ai Yoshioka
Division of Dermatology, Department of Internal Related, Graduate School of Medicine Kobe University Kobe Japan
3 shared publications - Shinya Hashimoto
Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine Kobe Japan
3 shared publications
Latest Publications
- Open Access
- 8 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
A role for condensin-mediator interaction in mitotic chromosome organization
Condensin organizes eukaryotic genomes into three-dimensional (3D) chromosome architectures that support accurate chromosome segregation during mitosis. However, the molecular mechanisms underlying this organization remain unclear. Here, we identify a previously unrecognized interaction between the condensin subunit Cnd1 and the mediator subunit Pmc4 in fission yeast, Schizosaccharomyces pombe. We characterize a condensin mutation, cnd1-K658E, which disrupts this interaction and observe that it impairs the formation of condensin-mediated chromatin domains during mitosis, resulting in chromosome segregation defects. This condensin-mediator interaction facilitates condensin recruitment to highly transcribed genes and mitotically activated genes, the latter of which demarcate condensin-mediated domains. Moreover, 1,6-hexanediol treatment and Pmc4 mediator depletion impair expression of mitotically activated genes, diminish condensin enrichment at those boundary genes, and disrupt domain boundaries, suggesting that mediator contributes to mitotic gene expression and chromosome architecture via phase separation. Together, these results reveal a mechanism by which mitotic gene expression patterns shape condensin-mediated chromosome architecture to ensure faithful chromosome segregation.
- 8 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessA role for condensin-mediator interaction in mitotic chromosome organization
Condensin organizes eukaryotic genomes into three-dimensional (3D) chromosome architectures that support accurate chromosome segregation during mitosis. However, the molecular mechanisms underlying this organization remain unclear. Here, we identify a previously unrecognized interaction between the condensin subunit Cnd1 and the mediator subunit Pmc4 in fission yeast, Schizosaccharomyces pombe. We characterize a condensin mutation, cnd1-K658E, which disrupts this interaction and observe that it impairs the formation of condensin-mediated chromatin domains during mitosis, resulting in chromosome segregation defects. This condensin-mediator interaction facilitates condensin recruitment to highly transcribed genes and mitotically activated genes, the latter of which demarcate condensin-mediated domains. Moreover, 1,6-hexanediol treatment and Pmc4 mediator depletion impair expression of mitotically activated genes, diminish condensin enrichment at those boundary genes, and disrupt domain boundaries, suggesting that mediator contributes to mitotic gene expression and chromosome architecture via phase separation. Together, these results reveal a mechanism by which mitotic gene expression patterns shape condensin-mediated chromosome architecture to ensure faithful chromosome segregation.
- Open Access
Senotherapeutic potential against xeroderma pigmentosum
Xeroderma pigmentosum (XP) is an inherited photoaging syndrome caused by mutations in genes involved in the nucleotide excision repair (NER) pathway. XP patients exhibit hypersensitivity to ultraviolet (UV) radiation, leading to accelerated skin aging and requiring lifelong sun avoidance. Here, we demonstrate that UV-induced DNA damage triggers cellular senescence and up-regulates senescence-associated secretory phenotype (SASP) genes in melanocytes derived from an XP patient. To explore the potential therapeutics for XP, we developed a cisplatin-based drug screening system and identified JAK inhibitors and curcuminoids as promising senomorphic agents. In addition, two classes of senolytic agents, BCL-2-like protein inhibitors and HSP90 inhibitors, effectively eliminate senescent melanocytes. Further analysis demonstrates that senomorphic treatment effectively counteracts senescence and reduces SASP gene expression in XP-derived melanocytes. Moreover, genes in senescence-related pathways, including the JAK/STAT, Type I interferon (IFN-I), and PI3K/AKT pathways, which are activated by both UV irradiation and cisplatin treatment, are down-regulated by senomorphic treatment. This study highlights a potential senotherapeutic strategy for XP, which may help alleviate photoaging symptoms in XP patients.
Open AccessSenotherapeutic potential against xeroderma pigmentosum
Xeroderma pigmentosum (XP) is an inherited photoaging syndrome caused by mutations in genes involved in the nucleotide excision repair (NER) pathway. XP patients exhibit hypersensitivity to ultraviolet (UV) radiation, leading to accelerated skin aging and requiring lifelong sun avoidance. Here, we demonstrate that UV-induced DNA damage triggers cellular senescence and up-regulates senescence-associated secretory phenotype (SASP) genes in melanocytes derived from an XP patient. To explore the potential therapeutics for XP, we developed a cisplatin-based drug screening system and identified JAK inhibitors and curcuminoids as promising senomorphic agents. In addition, two classes of senolytic agents, BCL-2-like protein inhibitors and HSP90 inhibitors, effectively eliminate senescent melanocytes. Further analysis demonstrates that senomorphic treatment effectively counteracts senescence and reduces SASP gene expression in XP-derived melanocytes. Moreover, genes in senescence-related pathways, including the JAK/STAT, Type I interferon (IFN-I), and PI3K/AKT pathways, which are activated by both UV irradiation and cisplatin treatment, are down-regulated by senomorphic treatment. This study highlights a potential senotherapeutic strategy for XP, which may help alleviate photoaging symptoms in XP patients.
- 1 April 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (10) , 2285-2297.e13
Chemo-Senolytic Therapeutic Potential against Angiosarcoma
- 1 April 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (10) , 2285-2297.e13
Chemo-Senolytic Therapeutic Potential against Angiosarcoma
- Open Access
Chemo-senolytic therapeutic potential against angiosarcoma
Angiosarcoma is an aggressive soft-tissue sarcoma with a poor prognosis. Chemotherapy for this cancer typically employs paclitaxel, one of the taxanes (genotoxic drugs), although it has a limited effect due to chemoresistance for prolonged treatment. Here we examine a new angiosarcoma treatment approach that combines chemotherapeutic and senolytic agents. We first find that the chemotherapeutic drugs, cisplatin and paclitaxel, efficiently induce cellular senescence of angiosarcoma cells. Subsequent treatment with a senolytic agent, ABT-263, eliminates senescent cells through the activation of the apoptotic pathway. In addition, expression analysis indicates that senescence-associated secretory phenotype (SASP) genes are activated in senescent angiosarcoma cells and that ABT-263 treatment eliminates senescent cells expressing genes in the type-I interferon (IFN-I) pathway. Moreover, we show that cisplatin treatment alone requires a high dose to remove angiosarcoma cells, whereas a lower dose of cisplatin is sufficient to induce senescence, followed by the elimination of senescent cells by senolytic treatment. This study sheds light on a potential therapeutic strategy against angiosarcoma by combining a relatively low dose of cisplatin with the ABT-263 senolytic agent, which can help ease the deleterious side effects of chemotherapy.
Open AccessChemo-senolytic therapeutic potential against angiosarcoma
Angiosarcoma is an aggressive soft-tissue sarcoma with a poor prognosis. Chemotherapy for this cancer typically employs paclitaxel, one of the taxanes (genotoxic drugs), although it has a limited effect due to chemoresistance for prolonged treatment. Here we examine a new angiosarcoma treatment approach that combines chemotherapeutic and senolytic agents. We first find that the chemotherapeutic drugs, cisplatin and paclitaxel, efficiently induce cellular senescence of angiosarcoma cells. Subsequent treatment with a senolytic agent, ABT-263, eliminates senescent cells through the activation of the apoptotic pathway. In addition, expression analysis indicates that senescence-associated secretory phenotype (SASP) genes are activated in senescent angiosarcoma cells and that ABT-263 treatment eliminates senescent cells expressing genes in the type-I interferon (IFN-I) pathway. Moreover, we show that cisplatin treatment alone requires a high dose to remove angiosarcoma cells, whereas a lower dose of cisplatin is sufficient to induce senescence, followed by the elimination of senescent cells by senolytic treatment. This study sheds light on a potential therapeutic strategy against angiosarcoma by combining a relatively low dose of cisplatin with the ABT-263 senolytic agent, which can help ease the deleterious side effects of chemotherapy.
- Open Access
Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the common malignant tumors with high lethal rate and poor prognosis. Dysregulation of many genes have been reported to be involved in the occurrence and development of PDAC. However, as a highly conserved gene in eukaryotes, the role of Fasciculation and Elongation protein Zeta 2 (FEZ2) in pancreatic cancer progression is not clear. In this study, we identified the oncogenic effect of FEZ2 on PDAC. By mining of The Cancer Genome Atlas (TCGA) database, we found that FEZ2 was upregulated in PDAC tissues and FEZ2 expression was negatively regulated by its methylation. Moreover, high expression and low methylation of FEZ2 correlated with poor prognosis in PDAC patients. Besides, we found that FEZ2 could promote PDAC cells proliferation, migration and 5-FU resistance in vitro. Furthermore, Gene pathway enrichment analysis demonstrated a positive correlation between Wnt signaling activation and FEZ2 expression in PDAC patients. Western blot showed that FEZ2 knockdown significantly suppressed β-catenin expression. Collectively, our finding revealed that FEZ2 functioned as a potential oncogene on PDAC progression and migration, and the expression of FEZ2 had guidance value for the treatment and chemotherapy program of PDAC patients.
Open AccessIdentification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the common malignant tumors with high lethal rate and poor prognosis. Dysregulation of many genes have been reported to be involved in the occurrence and development of PDAC. However, as a highly conserved gene in eukaryotes, the role of Fasciculation and Elongation protein Zeta 2 (FEZ2) in pancreatic cancer progression is not clear. In this study, we identified the oncogenic effect of FEZ2 on PDAC. By mining of The Cancer Genome Atlas (TCGA) database, we found that FEZ2 was upregulated in PDAC tissues and FEZ2 expression was negatively regulated by its methylation. Moreover, high expression and low methylation of FEZ2 correlated with poor prognosis in PDAC patients. Besides, we found that FEZ2 could promote PDAC cells proliferation, migration and 5-FU resistance in vitro. Furthermore, Gene pathway enrichment analysis demonstrated a positive correlation between Wnt signaling activation and FEZ2 expression in PDAC patients. Western blot showed that FEZ2 knockdown significantly suppressed β-catenin expression. Collectively, our finding revealed that FEZ2 functioned as a potential oncogene on PDAC progression and migration, and the expression of FEZ2 had guidance value for the treatment and chemotherapy program of PDAC patients.
- 1 December 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 131-136
Photoplethysmographic Signals Identification Method Based On Image Coding
The pulse wave signal has non-stationary and non-linear characteristics. In order to apply the advantages of neural network recognition on 2D images to pulse wave identification, a Gram angle field-convolutional neural network (PPG-GAF-CNN) pulse wave identification model is proposed. Using the two methods of Gram angle difference field (GADF) and Gram angle sum field (GASF) in the Gram angle field (GAF) to converting the pulse wave signal into a 2-D image, extract the image features and input the optimized CNN Model, obtaining the ideal recognition accuracy. By studying the influence of network parameters, different network layers and different diagnosis methods on the fault diagnosis model, the optimal combination of models is constructed. The test results show that GADF-CNN has higher recognition accuracy than the GASF-CNN, which has a reliable effect in pulse wave identification.
- 1 December 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 131-136
Photoplethysmographic Signals Identification Method Based On Image Coding
The pulse wave signal has non-stationary and non-linear characteristics. In order to apply the advantages of neural network recognition on 2D images to pulse wave identification, a Gram angle field-convolutional neural network (PPG-GAF-CNN) pulse wave identification model is proposed. Using the two methods of Gram angle difference field (GADF) and Gram angle sum field (GASF) in the Gram angle field (GAF) to converting the pulse wave signal into a 2-D image, extract the image features and input the optimized CNN Model, obtaining the ideal recognition accuracy. By studying the influence of network parameters, different network layers and different diagnosis methods on the fault diagnosis model, the optimal combination of models is constructed. The test results show that GADF-CNN has higher recognition accuracy than the GASF-CNN, which has a reliable effect in pulse wave identification.
- Open Access
- 31 August 2020
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 11
Inhibition of miR-27b Regulates Lipid Metabolism in Skeletal Muscle of Obese Rats During Hypoxic Exercise by Increasing PPARγ Expression
Hypoxic exercise may represent a novel therapeutic strategy to reduce and prevent obesity through the regulation of lipid metabolism. During hypoxic exercise, the targeting of peroxisome proliferator-activated receptor gamma (PPARγ) by miR-27b has been proposed to be one of the mechanisms involved in the modulation of lipid metabolism. We have previously shown that miR-27b can repress PPARγ and lipid metabolism-associated factors, thereby affecting lipid metabolism during hypoxic exercise in a rat model of obesity. In the current study, we aimed to confirm the role of miR-27b in the regulation of lipid metabolism. First, miR-27b expression was either upregulated or downregulated through the injection of adeno-associated virus (AAV) 9 containing a miR-27b expression cassette or miR-27b-3p inhibitor, respectively, into the right gastrocnemius muscle of obese rats. The rats were then subjected to a 4-week program of hypoxic exercise, and a series of parameters related to lipid metabolism were systematically evaluated, including body composition, blood lipid levels, miR-27b RNA levels, and mRNA and protein levels of PPARγ and those of its downstream lipid metabolism-associated factors. No significant differences were found in body composition between rats expressing different levels of miR-27b. However, regarding blood lipids, miR-27b overexpression led to increased concentrations of triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and free fatty acids (FFAs), while inhibition of miR-27b decreased the total cholesterol (TC) level and increased that of high-density lipoprotein cholesterol (HDL-C). At the mRNA level, miR-27b overexpression downregulated the expression of Pparγ, but upregulated that of lipid metabolism-associated factors such as heart-type fatty acid-binding protein (H-FABP), fatty acid transport protein 1 (FATP1), adipose triglyceride lipase (ATGL), and lipoprotein lipase (LPL), whereas miR-27b inhibition elicited the opposite effect; however, inhibition of miR-27b led to elevated cholesterol 7 alpha-hydroxylase (CYP7A1) and fatty acid translocase 36 (CD36) levels. Similarly, at the protein level, miR-27b overexpression promoted a decrease in the concentration of PPARγ, whereas miR-27b inhibition led to an increase in PPARγ levels, as well as those of CYP7A1, CD36, ATGL, and LPL. Overall, our results indicated that hypoxic exercise regulates lipid metabolism via the miR-27b/PPARγ pathway and modulates ATGL and LPL expression through inducing their post-transcriptional modifications.
- 31 August 2020
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 11
Open AccessInhibition of miR-27b Regulates Lipid Metabolism in Skeletal Muscle of Obese Rats During Hypoxic Exercise by Increasing PPARγ Expression
Hypoxic exercise may represent a novel therapeutic strategy to reduce and prevent obesity through the regulation of lipid metabolism. During hypoxic exercise, the targeting of peroxisome proliferator-activated receptor gamma (PPARγ) by miR-27b has been proposed to be one of the mechanisms involved in the modulation of lipid metabolism. We have previously shown that miR-27b can repress PPARγ and lipid metabolism-associated factors, thereby affecting lipid metabolism during hypoxic exercise in a rat model of obesity. In the current study, we aimed to confirm the role of miR-27b in the regulation of lipid metabolism. First, miR-27b expression was either upregulated or downregulated through the injection of adeno-associated virus (AAV) 9 containing a miR-27b expression cassette or miR-27b-3p inhibitor, respectively, into the right gastrocnemius muscle of obese rats. The rats were then subjected to a 4-week program of hypoxic exercise, and a series of parameters related to lipid metabolism were systematically evaluated, including body composition, blood lipid levels, miR-27b RNA levels, and mRNA and protein levels of PPARγ and those of its downstream lipid metabolism-associated factors. No significant differences were found in body composition between rats expressing different levels of miR-27b. However, regarding blood lipids, miR-27b overexpression led to increased concentrations of triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and free fatty acids (FFAs), while inhibition of miR-27b decreased the total cholesterol (TC) level and increased that of high-density lipoprotein cholesterol (HDL-C). At the mRNA level, miR-27b overexpression downregulated the expression of Pparγ, but upregulated that of lipid metabolism-associated factors such as heart-type fatty acid-binding protein (H-FABP), fatty acid transport protein 1 (FATP1), adipose triglyceride lipase (ATGL), and lipoprotein lipase (LPL), whereas miR-27b inhibition elicited the opposite effect; however, inhibition of miR-27b led to elevated cholesterol 7 alpha-hydroxylase (CYP7A1) and fatty acid translocase 36 (CD36) levels. Similarly, at the protein level, miR-27b overexpression promoted a decrease in the concentration of PPARγ, whereas miR-27b inhibition led to an increase in PPARγ levels, as well as those of CYP7A1, CD36, ATGL, and LPL. Overall, our results indicated that hypoxic exercise regulates lipid metabolism via the miR-27b/PPARγ pathway and modulates ATGL and LPL expression through inducing their post-transcriptional modifications.
- 28 July 2016
- Published by SAGE Publications in High Performance Polymers
- Vol. 28 (7) , 761-772
Nonisothermal crystallization kinetics of polyphenylene sulfide composites based on organic clay modified by benzimidazolium salt
Polyphenylene sulfide (PPS)/organic clay nanocomposites were prepared by simple melt blending. A synthesized benzimidazolium salt was used to modify the sodium montmorillonite in order to improve the compatibility with the PPS. The nonisothermal crystallization kinetics of PPS/organic clay composites were investigated by differerntial scanning calorimetry(DSC). It was observed that the crystallization peak temperature of PPS/organic clay composites was higher than pure PPS at various cooling rates. Several models such as the Ozawa and Mo equation were used to characterize the nonisothermal cooling crystallization kinetics of the PPS/organic clay composites. The results indicated that the Ozawa equation was not successful, while the Mo equation was successful to describe the nanoisothermal ctystallization kinetics of PPS/organic clay nanocomposites. The results also indicated that organic clay not only served as heterogeneous nucleating agents for PPS crystallization at lower content but also restricted the mobility and diffusion of PPS chains at higher content. These results were further supported by the crystallization activation energy of the samples determined by the Kissinger method.
- 28 July 2016
- Published by SAGE Publications in High Performance Polymers
- Vol. 28 (7) , 761-772
Nonisothermal crystallization kinetics of polyphenylene sulfide composites based on organic clay modified by benzimidazolium salt
Polyphenylene sulfide (PPS)/organic clay nanocomposites were prepared by simple melt blending. A synthesized benzimidazolium salt was used to modify the sodium montmorillonite in order to improve the compatibility with the PPS. The nonisothermal crystallization kinetics of PPS/organic clay composites were investigated by differerntial scanning calorimetry(DSC). It was observed that the crystallization peak temperature of PPS/organic clay composites was higher than pure PPS at various cooling rates. Several models such as the Ozawa and Mo equation were used to characterize the nonisothermal cooling crystallization kinetics of the PPS/organic clay composites. The results indicated that the Ozawa equation was not successful, while the Mo equation was successful to describe the nanoisothermal ctystallization kinetics of PPS/organic clay nanocomposites. The results also indicated that organic clay not only served as heterogeneous nucleating agents for PPS crystallization at lower content but also restricted the mobility and diffusion of PPS chains at higher content. These results were further supported by the crystallization activation energy of the samples determined by the Kissinger method.